United States· US:0169-2081_ff2589ac-650f-4740-984d-e950f785c1fc
Alhemo
A concizumab product containing concizumab, registered in United States by Novo Nordisk. The same ATC class is registered in 11 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Concizumab is registered in 11 of 19 countries.
Countries holding a registration under ATC B02BX10 (concizumab), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 8 of them publish a price we can compare per daily dose
Concizumab · ATC B02BX10
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Statesprice
Price per daily dose
What a daily dose of concizumab costs, country by country.
Normalised to the WHO defined daily dose (14 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Concizumab · price per daily dose (14 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1227.21
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- CONCIZUMAB
- Manufacturer
- Novo Nordisk
- Country
- United States (US)
- ATC code
- B02BX10
- ATC class
- Concizumab
- Defined daily dose
- 14 mg, P
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1101692081031 SYRINGE, PLASTIC in 1 CARTON (0169-2081-03) / 3 mL in 1 SYRINGE, PLASTIC
- ndc110169-2081-03
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Concizumab in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- IrelandAlhemo 150 mg/1.5 mL solution for injection in pre-filled penNovo Nordisk A/S
- NetherlandsAlhemo 150 mg/1,5 ml oplossing voor injectie in een voorgevulde penNovo Nordisk A.S.
- FranceALHEMO 150 mg/1,5 mL, solution injectable en stylo prérempliNOVO NORDISK (DANEMARK)
- CzechiaALHEMONovo Nordisk A/S, Bagsvaerd
- SwitzerlandAlhemo
- BelgiumAlhemo 15 mg/1.5 mlNovo Nordisk
- IcelandAlhemoNovo Nordisk A/S*
- PolandAlhemoNovo Nordisk A/S
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Alhemo
- Norway · Alhemo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1a8d4484-6d55-439f-8dbd-0e36f983fdb5 GET /v1/drugs/1a8d4484-6d55-439f-8dbd-0e36f983fdb5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "SUBCUTANEOUS",
"source": "ndc",
"strength": "100",
"substance": "CONCIZUMAB",
"productndc": "0169-2081",
"dosage_form": "INJECTION, SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "BLA761315",
"marketing_category": "BLA"
}See everything about concizumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.